Market Research Logo

Japan Pharmaceuticals & Healthcare Q1 2018

Japan Pharmaceuticals & Healthcare Q1 2018

BMI View: Japan will continue to represent an interesting yet challenging proposition for pharmaceutical companies. On the one hand, strong preference for brand-name prescription and the modern healthcare services will continue to support the uptake of latest medicines. On the other, downward price pressures have become a mainstay of the market, given the authorities' need to contain public insurance costs. On balance, however, the Japanese pharmaceutical market will remain of interest for multinationals, especially given the high per-capita spend on medicines."


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Japan 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Japan 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Japan 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Japan 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Japan 2013-2021)
Prescription Drug Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Japan 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Japan 2013-2021)
Generic Drug Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Japan 2013-2021)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Japan 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Japan 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Japan 2015-2021)
Industry Risk Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Regulatory Review
Intellectual Property Issues
Table: Re-examination Period
Pricing & Reimbursement
Table: Special Market Expansion Re-Pricing Formulas
Market Overview
Table: Healthcare Resources (Japan 2011-2016)
Table: Healthcare Personnel (Japan 2011-2016)
Table: Healthcare Activity (Japan 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Japan
Table: Japan: Dementia Cases And Types Across Different Areas
Competitive Landscape
Research-Based Industry
Table: Companies Represented By The JPMA
Table: Multinational Pharmaceutical Firm Activity
Generic Drug Industry
Table: Members Of The Japan Generic Medicines Association
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Astellas
AstraZeneca
Daiichi Sankyo
Eisai
GlaxoSmithKline
Merck & Co
Mitsubishi Tanabe
Novartis
Pfizer
Sanofi
Sawai Pharmaceutical
Takeda Pharmaceutical Company
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Japan 1990-2025)
Table: Key Population Ratios (Japan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Japan 1990-2025)
Table: Population By Age Group (Japan 1990-2025)
Table: Population By Age Group % (Japan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report